HDFCCC Newsletter
San Francisco Strongly Supports End to Selling Flavored Tobacco Products
On June 5th, San Francisco voters overwhelmingly approved Proposition E, upholding the city's law banning the sale of flavored tobacco products such as menthol cigarettes and candy-flavored vaping liquids. Dr. Valerie Yerger of the San Francisco Cancer Initiative (SF CAN) Menthol Project and Carol McGruder of the African American Tobacco Control Leadership Council—both pictured above with Drs. Alan Ashworth and Robert Hiatt—led the efforts of SF CAN in helping develop the initial ordinance with partners and Supervisor Malia Cohen. [read more]
news View UCSF Highlights from ASCO Annual Meeting
UCSF had an impressive presence at ASCO 2018 in Chicago. One of the world's most prestigious gatherings of oncology professionals, the conference drew more than 40,000 cancer experts focusing on groundbreaking research and advances in cancer.
news Checking In with Molecular Oncology Initiative Director Alejandro Sweet-Cordero, MD
The Molecular Oncology Initiative (MOI) has become central to UCSF's precision medicine efforts, especially for cancer. In this Q&A, Dr. Alejandro Sweet-Cordero sheds light on the unique UCSF 500 assay and what's ahead for the MOI.
  Join your colleagues at the first annual Courage Over Cancer 5K & 10K Walk/Run in Crissy Field on Saturday, August 11th!

Proceeds will benefit the GI Oncology Survivorship Clinic, supporting cutting edge research and initiatives to promote wellness amongst patients with gastrointestinal cancers.

> view event details
> register or donate

Awards & Distinctions
Eric Small, MD has been appointed Chief Scientific Officer of the Helen Diller Family Comprehensive Cancer Center. Read more.
Katherine Matthay, MD received a Lifetime Achievement Award for neuroblastoma research from the Advances in Neuroblastoma Research Association.
Lauren Levine, MD, MS received a Young Investigator Award from the Conquer Cancer Foundation of ASCO for her project, "Defining the contribution of systemic immunity to effective tumor rejection in advanced melanoma."
Timothy T. Ferng, MD received a Young Investigator Award from the Conquer Cancer Foundation of ASCO for his project, "Identifying synthetic lethal interactions in FLT3-mutant acute myeloid leukemia using dynamic BH3 profiling."
Marisa Quinn, RN, MBA and Bart Reyes, BSN, RN each received an Excellence in Nursing Leadership Award from the UCSF Dept. of Nursing and the Professional Development Council.
Kayo Tsuruta, CN III received a Jeanne Yalon Excellence in Oncology Nursing Award from the UCSF Dept. of Nursing and the Professional Development Council.
Lisa Tsang, BScN, MN, RN, CPHON received an Excellence in Advanced Practice Nursing Award from the UCSF Dept. of Nursing and the Professional Development Council.
Laura Esserman, MD, MBA received an OncLive Giants of Cancer Care Award.
Laura Esserman, MD, MBA was named among the 2018 Most Influential Women in Bay Area Business by the San Francisco Business Times.
The Helen Diller Family Comprehensive Cancer Center successfully renewed its Cancer Center Support Grant, an NCI P30 grant that will continue to fund the Center's infrastructure. The renewal also extends the HDFCCC's elite "Comprehensive" designation, which is characterized by scientific excellence and the ability to integrate diverse research approaches in the fight against cancer.
In the News
news How Wendell Lim's Idea for Synthetic Cells Took Silicon Valley By Storm
UCSF | Jun 12, 2018
news HDFCCC Reaffirms Support for National Effort on HPV Vaccine Recommendations
HDFCCC | Jun 7, 2018
news Resounding Win for Flavored Tobacco Ban in San Francisco
KTVU | Jun 6, 2018
news Continuing the Conversation on BRCA1 and BRCA2 Mutations
UCSF Radiology | Jun 4, 2018
news Using Facebook to Help Young Adults Quit Smoking
UCSF | May 24, 2018
news Do Kids Need a Different Kind of Sunscreen?
CNN | May 22, 2018
Recent Publications

Reeves MQ, Kandyba E, Harris S, Del Rosario R, Balmain A. Multicolour lineage tracing reveals clonal dynamics of squamous carcinoma evolution from initiation to metastasis. Nat Cell Biol. 2018 Jun;20(6):699-709.

Li M, Mulkey F, Jiang C, O'Neill BH, Schneider BP, Shen F, Friedman PN, Momozawa Y, Kubo M, Niedzwiecki D, Hochster HS, Lenz HJ, Atkins JN, Rugo HS, Halabi S, Kelly WK, McLeod HL, Innocenti F, Ratain MJ, Venook A, Owzar K, Kroetz D. Identification of a Genomic Region Between SLC29A1 and HSP90AB1 Associated with Risk of Bevacizumab-Induced Hypertension: CALGB 80405 (Alliance). Clin Cancer Res. 2018 Jun 5.

Buerki RA, Chheda ZS, Okada H. Immunotherapy of Primary Brain Tumors: Facts and Hopes. Clin Cancer Res. 2018 Jun 5.

Leonard B, Brand TM, O'Keefe RA, Lee E, Zang Y, Kemmer JD, Li H, Grandis JR, Bhola NE. BET inhibition overcomes receptor tyrosine kinase-mediated cetuximab resistance in HNSCC. Cancer Res. 2018 May 23.

Jun 15: Inaugural Integrative Oncology Symposium - UCSF Mission Bay
Highlighting ongoing work at UCSF in the area of integrative oncology.
Jun 21: Cell Biology, Cancer, and Immunology RIP Seminar - UCSF Parnassus
Featuring presenters Adil Daud, MD, and Kevin Barry, PhD (Krummel Lab).
Jun 30: Cancer Research Institute Immunotherapy Patient Summit - Hilton San Francisco
Featuring Katy Tsai, MD, Lewis Lanier, PhD, and Terence Friedlander, MD.
Employment and Training
Program Manager, UCSF Molecular Oncology Initiative
Professional Researcher, UCSF Molecular Oncology Initiative
Junior or Assistant Specialist, UCSF Multiple Myeloma Translational Initiative laboratory
Postdoctoral positions in the UCSF Institute for Human Genetics
View opportunities from QB3 startups
  UNSUBSCRIBE | ABOUT | CONTACT facebook twitter